A detailed history of Ahrens Investment Partners LLC transactions in Embecta Corp. stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 15 shares of EMBC stock, worth $304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Holding current value
$304
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$23.07 - $32.77 $346 - $491
15 New
15 $0
Q2 2022

Aug 02, 2022

BUY
$24.78 - $33.36 $371 - $500
15 New
15 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Ahrens Investment Partners LLC Portfolio

Follow Ahrens Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.